Literature DB >> 16129022

P2Y1 gene polymorphism and ADP-induced platelet response.

P Fontana, V Remones, J-L Reny, M Aiach, P Gaussem.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16129022     DOI： 10.1111/j.1538-7836.2005.01483.x

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN： 1538-7836            Impact factor:   5.824


× No keyword cloud information.
  4 in total

1.  Single nucleotide polymorphisms of the purinergic 1 receptor are not associated with myocardial infarction in a Latvian population.

Authors:  Vita Ignatovica; Gustavs Latkovskis; Raitis Peculis; Kaspars Megnis; Helgi B Schioth; Iveta Vaivade; Davids Fridmanis; Valdis Pirags; Andrejs Erglis; Janis Klovins
Journal:  Mol Biol Rep       Date:  2011-06-04       Impact factor: 2.316

2.  Quantification of recombinant and platelet P2Y(1) receptors utilizing a [(125)I]-labeled high-affinity antagonist 2-iodo-N(6)-methyl-(N)-methanocarba-2'-deoxyadenosine-3',5'-bisphosphate ([(125)I]MRS2500).

Authors:  Philippe Ohlmann; Sonia de Castro; Garth G Brown; Christian Gachet; Kenneth A Jacobson; T Kendall Harden
Journal:  Pharmacol Res       Date:  2010-06-04       Impact factor: 7.658

3.  The platelet P2Y(12) receptor under normal and pathological conditions. Assessment with the radiolabeled selective antagonist [(3)H]PSB-0413.

Authors:  Philippe Ohlmann; Anna Lecchi; Ali El-Tayeb; Christa E Müller; Marco Cattaneo; Christian Gachet
Journal:  Purinergic Signal       Date:  2012-08-15       Impact factor: 3.765

Review 4.  Pharmacokinetic, pharmacodynamic and pharmacogenetic profile of the oral antiplatelet agent ticagrelor.

Authors:  Renli Teng
Journal:  Clin Pharmacokinet       Date:  2012-05-01       Impact factor: 6.447
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.